Developing, funding and conducting clinical trials in immune tolerance
A clinical study for relapsing multiple sclerosis
BEAT-MS is currently enrolling study participants
If you are at least 18 and have continued relapses or active MRI while taking prescription medicine for MS, you may be eligible.
Learn more ›
There are a number of U.S. Clinical Research Study Sites where participants will be enrolled in the BEAT-MS study.
A clinical trial comparing hemato-poietic stem cell transplantation to the most effective medications used to treat relapsing multiple sclerosis (MS).